The monthly or quarterly GST return reporting outward supplies — a pharmacy's sales.
GSTR-1 reports what you sold. For a retail pharmacy most of that is B2C, which is filed in summary rather than invoice by invoice, with B2B sales reported individually so the buyer can claim input credit against them.
The return is summarised by HSN and by rate, which is why the HSN code and GST rate recorded against each medicine at billing time determine whether the return can be produced without manual rework at month end. A shop that bills without recording HSN has to reconstruct it later from the purchase invoices.
GSTR-1 pairs with GSTR-3B, the summary return through which tax is actually paid and input credit claimed. The two must agree; mismatches between them are among the most common triggers for a notice.
Filing frequency depends on turnover — monthly, or quarterly under the QRMP scheme. Confirm which applies to your registration with your CA rather than assuming.
Free, no signup — GST-ready pharmacy billing.
Open GST-ready pharmacy billing →Batch numberBreakage and damageCDSCOCGST, SGST and IGSTCold chainCredit noteDPCO (Drugs Prices Control Order)Drug licence (Form 20 / Form 21)Expiry returnFEFO (First Expiry First Out)Generic vs branded medicineGSTR-1GSTR-3BHSN codeInput tax credit (ITC)Loose sale (cut strip)MRP (Maximum Retail Price)Narcotic registerNear-expiry stockNPPAPack factor (units per pack)Pharmacist registrationPTR (Price to Retailer)PTS (Price to Stockist)Purchase invoiceRed-border warning labelReorder levelRetail vs wholesale drug licenceReturn to vendor (RTV)Rule 65Rx symbolSalt compositionSchedule HSchedule H1Schedule XScheme goods (free goods)Shortbook (short book)Stock rotationStockist
This glossary is a practical reference for Indian retail pharmacy, not legal, tax or clinical advice. Requirements under the Drugs & Cosmetics Rules are enforced by state drug control authorities and vary; GST treatment should be confirmed with your CA. Verify anything you intend to rely on against the current notified position. As of August 2026.